Spots Global Cancer Trial Database for Retrospective Study in Sarcoma Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Retrospective Study in Sarcoma Patients
Official Title: Retrospective Study to Evaluate Efficacy and Safety of Trabectedin (Yondelis®) in Sarcoma Patients
Study ID: NCT03284320
Interventions
Study Description
Brief Summary: The objectives of this trial is to evaluate efficacy and safety of treatment with Trabectedin in a large cohort of German patients with soft tissue and bone sarcomas.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University Medicine Greifswald, Department of Internal Medicine C, Greifswald, , Germany
Contact Details
Name: Daniel Pink, MD
Affiliation: University Medicine Greifswald
Role: PRINCIPAL_INVESTIGATOR
Name: Peter Reichardt, MD
Affiliation: Sarcoma Center Berlin-Brandenburg; HELIOS Hospital Berlin Buch
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
